Formation of metabolites of [Arg8]vasopressin (AVP) by brain peptidases
- 3 March 1986
- journal article
- Published by Wiley in FEBS Letters
- Vol. 197 (1-2) , 164-168
- https://doi.org/10.1016/0014-5793(86)80319-2
Abstract
[Cyt6]AVP-(3–9), an intermediate in the metabolism of AVP-(1–9) in vitro, was used to investigate the mechanism of formation of centrally active AVP metabolites. Exposure of [Cyt6]AVP-(3–9) to rat brain membranes resulted in formation of [Cyt6]AVP-(4–9),-(5–9), [pGlu6,Cyt6]AVP-(4–9) and AVP-(3–5), which were isolated and chemically identified. Products derived from cleavage of the C-terminus of the substrate were absent. Time-course experiments further indicated that the conversion process is predominantly mediby an aminopeptidase-like mechanism. The conversion of [Cyt6]AVP-(3–9) by membranes from hippocampus, amygdala and septum was quantitatively and qualitatively similar. The results point to a major role of aminopeptidase activity in the metabolic conversion of AVP and the formation of centrally active AVP metabolitesKeywords
This publication has 4 references indexed in Scilit:
- Autoradiographic localization of binding sites for the arginine-vasopressin (VP) metabolite, VP4–9, in rat brainNeuroscience Letters, 1985
- Substances resembling C-terminal vasopressin fragments are present in the brain but not in the pituitary glandBrain Research, 1984
- A Major Metabolite of Arginine Vasopressin in the Brain Is a Highly Potent NeuropeptideScience, 1983
- Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structuresBrain Research, 1979